FDA Issues a Reminder on Excipients in Dietary Supplements

January 21, 2014

In the new guidance on substances that can be added to foods, including beverages and dietary supplements, the FDA reminds manufacturers that the excipients added to oral dosage forms of these products need to “meet the same requirements as substances added to conventional foods.” This means that the substances added as fillers, coatings, antioxidants, disintegrants, etc. must be used either in accordance with a food additive regulation or be considered GRAS for the intended use. The only exceptions to the above are those substances excepted from the food additive definition.

The practice of relying on the presence of an excipient in the FDA’s Inactive Ingredient Database cannot assure that use of the same substance in a dietary supplement is acceptable. The risk-benefit balance accepted by the FDA for excipients in drugs is different than that for excipients in dietary supplements. For drugs, the FDA may find that short-term use or the serious nature of the disease a drug is intended to treat outweighs potential toxicity from an excipient. For dietary supplements, a similar level of excipient toxicity would not be tolerated when weighed against the potential for the long-term use of the supplement in a generally healthy population.

ProPharma's team are experts in assessing and qualifying the safety of excipients used in drugs and dietary supplements. Clients with questions are encouraged to call us to assist.

If you have any questions or thoughts on this blog post or others, please contact us.

TAGS:

FDA Recognizes August as National Immunization Awareness Month

National Immunization Awareness Month provides us an opportunity to think about how far the development and advancement of immunization science has come, and its impact on public health. The U.S....

How to Avoid Common Pitfalls in the Development of Biosimilars

As many blockbuster biologicals face the expiration of their patents, so-called "patent cliff", many biotech businesses direct their attention to the field of biosimilars. The development of...

February 6, 2014

FDA Revisits the Topic of INDs for Dietary Supplements

One of the fundamental disconnects in the dietary supplement world is that despite the fact that manufacturers of dietary supplements are not allowed to make claims regarding effects on diseases,...